Skip to main content
Tech.euFundingExplorerBeta

Phlox Therapeutics

Phlox Therapeutics is developing Ribonucleic acid (RNA)-based gene therapies to treat cardiomyopathies, disorders that affect the heart muscle.

Total raised
€1.9M
€1,900,000
Funding rounds
1
Investors
5
distinct backers
Active since
2024-11
latest 2024-11

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood33
base rate 30% for Other
  • In typical raise window
  • Low backer re-investment

Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Related news

Similar companies

same sector or country